Medistim ASA (STO:MEDIO)
220.00
0.00 (0.00%)
At close: Mar 3, 2026
Medistim ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 212.09 | 179.21 | 153.87 | 152.64 | 129.49 |
Cash & Short-Term Investments | 212.09 | 179.21 | 153.87 | 152.64 | 129.49 |
Cash Growth | 18.35% | 16.47% | 0.81% | 17.88% | 80.12% |
Accounts Receivable | 86.39 | 68.98 | 74.3 | 101.66 | 68.63 |
Other Receivables | 18.11 | 10.75 | 9.94 | 8.83 | 4.88 |
Receivables | 104.5 | 79.73 | 84.24 | 110.49 | 73.52 |
Inventory | 161.13 | 160.52 | 145.39 | 114.33 | 97.41 |
Prepaid Expenses | - | 5.64 | 4.67 | 4.55 | 6.08 |
Other Current Assets | 0 | 4.04 | 3.39 | 3.88 | - |
Total Current Assets | 477.72 | 429.13 | 391.57 | 385.89 | 306.5 |
Property, Plant & Equipment | 87.56 | 73.16 | 57.31 | 51.31 | 58.86 |
Goodwill | - | 14.13 | 14.13 | 14.13 | 14.13 |
Other Intangible Assets | 95.32 | 45.21 | 31.25 | 21.94 | 16.04 |
Long-Term Deferred Tax Assets | - | 9.02 | 5.14 | 3.59 | 3.24 |
Other Long-Term Assets | -0 | 4.32 | 6.33 | 5.79 | 4.48 |
Total Assets | 660.6 | 574.97 | 505.72 | 482.66 | 403.24 |
Accounts Payable | - | 17.73 | 25.08 | 24.47 | 13.21 |
Accrued Expenses | - | 35.95 | 28.46 | 32.75 | 30.82 |
Current Portion of Leases | - | 9.31 | 8.38 | 7.09 | 7.11 |
Current Income Taxes Payable | - | 27.38 | 28.4 | 25.87 | 20.33 |
Other Current Liabilities | 143.21 | 17.01 | 3.95 | 9.64 | 6.14 |
Total Current Liabilities | 143.21 | 107.37 | 94.28 | 99.82 | 77.6 |
Long-Term Leases | 37.5 | 25.06 | 9.26 | 10.02 | 17.08 |
Long-Term Unearned Revenue | 11.49 | 5.93 | 4.23 | 5.13 | 2.51 |
Other Long-Term Liabilities | -0 | - | -0 | - | -0 |
Total Liabilities | 192.19 | 138.36 | 107.78 | 114.97 | 97.19 |
Common Stock | 4.59 | 4.59 | 4.59 | 4.59 | 4.59 |
Additional Paid-In Capital | 44.17 | 67.66 | 66.6 | 60.59 | 55.2 |
Retained Earnings | - | 328.8 | 307.38 | 285.74 | 240.16 |
Treasury Stock | - | -0.01 | -0.01 | -0.02 | -0.03 |
Comprehensive Income & Other | 419.65 | 35.58 | 19.39 | 16.8 | 6.14 |
Shareholders' Equity | 468.41 | 436.61 | 397.94 | 367.69 | 306.05 |
Total Liabilities & Equity | 660.6 | 574.97 | 505.72 | 482.66 | 403.24 |
Total Debt | 37.5 | 34.36 | 17.64 | 17.11 | 24.19 |
Net Cash (Debt) | 174.59 | 144.85 | 136.23 | 135.54 | 105.3 |
Net Cash Growth | 20.53% | 6.33% | 0.51% | 28.72% | 221.24% |
Net Cash Per Share | 9.55 | 7.91 | 7.45 | 7.42 | 5.77 |
Filing Date Shares Outstanding | 18.27 | 18.31 | 18.28 | 18.25 | 18.23 |
Total Common Shares Outstanding | 18.27 | 18.31 | 18.28 | 18.25 | 18.23 |
Working Capital | 334.51 | 321.76 | 297.28 | 286.07 | 228.89 |
Book Value Per Share | 25.63 | 23.84 | 21.77 | 20.14 | 16.79 |
Tangible Book Value | 373.09 | 377.28 | 352.57 | 331.62 | 275.88 |
Tangible Book Value Per Share | 20.42 | 20.60 | 19.29 | 18.17 | 15.13 |
Machinery | - | 106.92 | 103.44 | 92.98 | 85.87 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.